Literature DB >> 16184522

Recurrent primary sclerosing cholangitis after liver transplantation: a magnetic resonance cholangiography study with analyses of predictive factors.

Bjorn Brandsaeter1, Erik Schrumpf, Oystein Bentdal, Kurt Brabrand, Hans Jorgen Smith, Andreas Abildgaard, Ole Petter Clausen, Kristian Bjoro.   

Abstract

Primary sclerosing cholangitis (PSC) is a well-established indication for orthotopic liver transplantation (OLT), but post-OLT bile duct strictures complicate the outcome for these patients. These strictures might represent recurrent PSC (rPSC). To estimate the risk factors for post-OLT non-anastomotic bile duct strictures in PSC patients and to find their possible etiology, we performed magnetic resonance cholangiography (MRC) and angiography (MRA) in all PSC patients who had undergone OLT and were alive (median follow-up 6.4 years, range 1.4-15.2 years). This group of PSC patients was compared to a group of 45 non-PSC patients who had also undergone OLT. A logistic regression analysis was performed to find predictors of rPSC. Bile duct strictures were found in 19/49 PSC patients and in 4/45 non-PSC patients (P = 0.001). In the PSC group nine patients without other possible explanations for bile duct strictures than rPSC were identified, i.e., the estimated risk of rPSC was 9/49 (18%); surprisingly similar changes were also seen in one patient without a pre-transplant PSC diagnosis. Severe liver disease due to rPSC was seen in 4/9 patients (one patient died and three are being evaluated for re-OLT). Steroid-resistant rejection was the only significant predictor for rPSC. In conclusion, our study shows that by the use of MRC we found more bile duct strictures in PSC patients post-OLT compared to controls and that steroid-resistant rejections was a predictor of such changes.

Entities:  

Mesh:

Year:  2005        PMID: 16184522     DOI: 10.1002/lt.20444

Source DB:  PubMed          Journal:  Liver Transpl        ISSN: 1527-6465            Impact factor:   5.799


  16 in total

1.  Recommendations for the assessment and reporting of multivariable logistic regression in transplantation literature.

Authors:  A C Kalil; J Mattei; D F Florescu; J Sun; R S Kalil
Journal:  Am J Transplant       Date:  2010-07       Impact factor: 8.086

Review 2.  Primary sclerosing cholangitis as an intractable disease.

Authors:  Sumihito Tamura; Yasuhiko Sugawara; Norihiro Kokudo
Journal:  Intractable Rare Dis Res       Date:  2012-02

3.  Living donor and deceased donor liver transplantation for autoimmune and cholestatic liver diseases--an analysis of the UNOS database.

Authors:  Randeep Kashyap; Saman Safadjou; Rui Chen; Parvez Mantry; Rajeev Sharma; Vrishali Patil; Manoj Maloo; Charlotte Ryan; Carlos Marroquin; Christopher Barry; Gopal Ramaraju; Benedict Maliakkal; Mark Orloff
Journal:  J Gastrointest Surg       Date:  2010-07-09       Impact factor: 3.452

4.  The natural history of inflammatory bowel disease and primary sclerosing cholangitis after liver transplantation--a single-centre experience.

Authors:  Karli J Moncrief; Anamaria Savu; Mang M Ma; Vince G Bain; Winnie W Wong; Puneeta Tandon
Journal:  Can J Gastroenterol       Date:  2010-01       Impact factor: 3.522

Review 5.  Recurrence of autoimmune liver diseases after liver transplantation.

Authors:  Nabiha Faisal; Eberhard L Renner
Journal:  World J Hepatol       Date:  2015-12-18

Review 6.  Recurrence and rejection in liver transplantation for primary sclerosing cholangitis.

Authors:  Bjarte Fosby; Tom H Karlsen; Espen Melum
Journal:  World J Gastroenterol       Date:  2012-01-07       Impact factor: 5.742

Review 7.  Endoscopic and surgical management of primary sclerosing cholangitis.

Authors:  Anthony Michaels; Cynthia Levy
Journal:  Medscape J Med       Date:  2008-10-21

Review 8.  Primary sclerosing cholangitis.

Authors:  Marina G Silveira; Keith D Lindor
Journal:  Can J Gastroenterol       Date:  2008-08       Impact factor: 3.522

Review 9.  Transplantation in autoimmune liver diseases.

Authors:  Marcus Mottershead; James Neuberger
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

Review 10.  Post-Transplant Disease Recurrence in Pediatric PSC.

Authors:  Nisreen Soufi; Fateh Bazerbachi; Mark Deneau
Journal:  Curr Gastroenterol Rep       Date:  2018-08-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.